Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03618953
Title This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers (Kingfisher)
Acronym Kingfisher
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Turnstone Biologics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.